FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to experimental surgery, and concerns prevention of bleeding caused by the use of warfarin prior to surgery. To this end, a rabbit-male chinchilla breed is given a solution containing fibrin monomer at a concentration of 11 mg/ml and urea at a concentration of 150 mg/ml one hour before the operation. Wherein dose of fibrin monomer is 0.25 mg/kg.
EFFECT: method is highly effective, since it not only reduces the amount of blood loss, but it is also safe to use.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTION OF BLEEDING CAUSED BY USE OF DABIGATRAN ETEXILATE IN EXPERIMENT | 2013 |
|
RU2552331C1 |
| METHOD FOR PREVENTING INTRAOPERATIVE BLEEDING CAUSED BY PREOPERATIVE INTRODUCTION OF HEPARINE | 2013 |
|
RU2544805C1 |
| METHOD OF PREVENTION OF BLEEDING CAUSED BY THE APPLICATION OF ANTIAGREGANTS, EXPERIMENT STAGE | 2017 |
|
RU2645630C1 |
| METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
| METHOD OF PATIENT MANAGEMENT AFTER TRICUSPID VALVE PROSTHETICS | 2009 |
|
RU2465894C2 |
| METHOD FOR PREVENTING AND TREATING INTRA- AND POSTOPERATIVE PARENCHYMAL HEMORRHAGE IN COMBINED LUNG OPERATIONS WITH PARTIAL OR TOTAL COSTAL PLEURECTOMY IN PATIENTS WITH INITIAL RISK OF DEVELOPING VENOUS THROMBOEMBOLIC COMPLICATIONS | 2019 |
|
RU2710232C1 |
| COMBINATION THERAPY FOR TREATING HEMORRHAGIC SHOCK | 2015 |
|
RU2651778C2 |
| COMBINATION THERAPY FOR TREATING HEMORRHAGIC SHOCK | 2018 |
|
RU2663464C1 |
| METHOD OF TREATMENT OF UPPER GASTROINTESTINAL BLEEDING | 2016 |
|
RU2657756C2 |
| METHOD OF INDUSTRIAL PRODUCTION OF FIBRIN-MONOMER FROM BLOOD PLASMA | 2012 |
|
RU2522237C2 |
